Weekly chemotherapy in advanced prostatic cancer

Weekly chemotherapy in advanced prostatic cancer

Item
http://www.wikidata.org/entity/Q35977021
Chemotherapy for hormone-refractory prostate cancerNon-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site GroupEpirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II studyWeekly epirubicin in patients with hormone-resistant prostate cancer.Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.Dissociation of bone formation markers in bone metastasis of prostate cancer.Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer.Salvage chemotherapy for hormone-refractory prostate cancer: Association of Adriamycin and ifosfamide.Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma.
P2860

Weekly chemotherapy in advanced prostatic cancer

Item
http://www.wikidata.org/entity/Q35977021
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Weekly chemotherapy in advanced prostatic cancer
@ast
Weekly chemotherapy in advanced prostatic cancer
@en
type
label
Weekly chemotherapy in advanced prostatic cancer
@ast
Weekly chemotherapy in advanced prostatic cancer
@en
prefLabel
Weekly chemotherapy in advanced prostatic cancer
@ast
Weekly chemotherapy in advanced prostatic cancer
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Weekly chemotherapy in advanced prostatic cancer
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932